131 related articles for article (PubMed ID: 6231607)
1. [Use of azlocillin in the treatment of Pseudomonas bronchopulmonary infections].
Arnaud A; Gevaudan MJ; Saadjian M; Dugue P; Charpin J
Presse Med; 1984 Mar; 13(13):834-7. PubMed ID: 6231607
[TBL] [Abstract][Full Text] [Related]
2. [Azlocillin treatment of Pseudomonas aeruginosa bronchopulmonary infections in children with cystic fibrosis].
Grenier B; Gilly R
Presse Med; 1984 Mar; 13(13):815-8. PubMed ID: 6231602
[TBL] [Abstract][Full Text] [Related]
3. [Monotherapy of Pseudomonas aeruginosa septicemia with azlocillin].
Godard J; Aubertin J; Borderon JC; Dureux JB; Motin J
Presse Med; 1984 Mar; 13(13):819-21. PubMed ID: 6231603
[TBL] [Abstract][Full Text] [Related]
4. [Role of azlocillin in the treatment of Pseudomonas urinary infections].
Canton P
Presse Med; 1984 Mar; 13(13):830-3. PubMed ID: 6231606
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy against Pseudomonas aeruginosa in cystic fibrosis. A study of carbenicillin, azlocillin or piperacillin in combination with tobramycin.
Møller NE; Eriksen KR; Feddersen C; Flensborg EW; Høiby N; Norn S; Rosendal K; Schiøtz PO; Skov PS
Eur J Respir Dis; 1982 Mar; 63(2):130-9. PubMed ID: 6461561
[TBL] [Abstract][Full Text] [Related]
6. Treatment of serious Pseudomonas infections with azlocillin.
Olive S; Mogabgab WJ; Holmes B; Pollock B; Pauling B; Beville R
J Antimicrob Chemother; 1983 May; 11 Suppl B():153-8. PubMed ID: 6619026
[TBL] [Abstract][Full Text] [Related]
7. Azlocillin in respiratory tract infections with Pseudomonas aeruginosa in children with cystic fibrosis.
Michalsen H; Bergan T
Chemotherapy; 1980; 26(2):135-40. PubMed ID: 7363708
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of the clinical activity of azlocillin. A multicenter study conducted in 14 centers].
Konopka CA
Presse Med; 1984 Mar; 13(13):808-11. PubMed ID: 6231600
[TBL] [Abstract][Full Text] [Related]
9. Azlocillin compared with carbenicillin in the treatment of bronchopulmonary infection due to Pseudomonas aeruginosa in cystic fibrosis.
Penketh A; Hodson ME; Gaya H; Batten JC
Thorax; 1984 Apr; 39(4):299-304. PubMed ID: 6426075
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of azlocillin, carbenicillin, mezlocillin and piperacillin against Pseudomonas aeruginosa.
Høiby N; Bremmelgaard A; Schouenborg P
Scand J Infect Dis Suppl; 1981; 29():27-30. PubMed ID: 6458882
[TBL] [Abstract][Full Text] [Related]
11. Pseudomonas infections of the lung treated with azlocillin. Microbiology, pharmacokinetics, clinic.
Daikos GK; Giamarellou H; Hadjipolydorou K; Kanellakopoulou K
Arzneimittelforschung; 1979; 29(12a):1976-8. PubMed ID: 120747
[TBL] [Abstract][Full Text] [Related]
12. The use of azlocillin to treat serious infections.
Neu HC; Francke EL; Ortiz-Neu C; Prince AS
J Antimicrob Chemother; 1983 May; 11 Suppl B():141-7. PubMed ID: 6619023
[TBL] [Abstract][Full Text] [Related]
13. Azlocillin and gentamicin in respiratory tract infections with Pseudomonas aeruginosa in patients with cystic fibrosis.
Malmborg AS; Alfredsson H; Kusoffsky E; Strandvik B
Scand J Infect Dis Suppl; 1981; 29():64-9. PubMed ID: 6947407
[TBL] [Abstract][Full Text] [Related]
14. [Current chemotherapy of infections caused by Pseudomonas aeruginosa (author's transl)].
Bauernfeind A; Petermüller C; Dietzel M
Infection; 1979; 7(1):21-6. PubMed ID: 422252
[TBL] [Abstract][Full Text] [Related]
15. Antibiotic treatment of chronic Pseudomonas aeruginosa infection in cystic fibrosis patients.
Møller NE; Høiby N
Scand J Infect Dis Suppl; 1981; 29():87-91. PubMed ID: 6458884
[TBL] [Abstract][Full Text] [Related]
16. [Pseudomonas aeruginosa meningitis treated with azlocillin. 5 cases].
Vilde JL; Vachon F; Humbert G; Bure A; Bricaire F
Presse Med; 1984 Mar; 13(13):822-4. PubMed ID: 6231604
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the in vitro activity of azlocillin and carbenicillin against 856 clinical bacterial isolates.
Skar AG; Midtvedt T; Dahl O
NIPH Ann; 1984 Jun; 7(1):13-9. PubMed ID: 6493580
[TBL] [Abstract][Full Text] [Related]
18. [Comparative antibacterial effect of azlocillin, ticarcillin and carbenicillin on pseudomonas bacteria].
Jotzoff M
Med Welt; 1981 Sep; 32(39):1448-9. PubMed ID: 7300647
[No Abstract] [Full Text] [Related]
19. Synergy of ciprofloxacin and azlocillin in vitro and in a neutropenic mouse model of infection.
Chin NX; Jules K; Neu HC
Eur J Clin Microbiol; 1986 Feb; 5(1):23-8. PubMed ID: 2938945
[TBL] [Abstract][Full Text] [Related]
20. Selection of variants of Pseudomonas aeruginosa resistant of Beta-lactam antibiotics.
Gwynn MN; Rolinson GN
Infection; 1980; 8(2):73-80. PubMed ID: 6771215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
